— Know what they know.
Not Investment Advice

RGEN NASDAQ

Repligen Corporation
1W: -4.2% 1M: +5.1% 3M: +28.4% YTD: +10.6% 1Y: +24.6% 3Y: +12.9% 5Y: -43.8%
$181.70
+4.47 (+2.52%)
 
Weekly Expected Move ±6.0%
$160 $171 $182 $193 $203
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 62 · $10.3B mcap · 53M float · 2.07% daily turnover · Short 70% of daily vol

Cash Flow Trends

Operating Cash Flow
$117M -33.1% ▼
5Y CAGR: +13.4%
Capital Expenditures
$24M +28.5% ▲
5Y CAGR: -2.2%
Free Cash Flow
$94M -34.1% ▼
5Y CAGR: +20.9%
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$191M -3272.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$128M$186M$42M-$26M$49M
Depreciation & Amort.$38M$57M$68M$87M$97M
Stock-Based Comp.$0$27M$26M$48M$33M
Change in Working Capital-$102M-$70M-$9M$61M-$51M
Other Non-Cash Items$48M-$27M-$15M$5M-$10M
Operating Cash Flow$119M$172M$114M$175M$117M
— Investing Activities —
Capital Expenditures-$71M-$85M-$36M-$26M-$24M
Acquisitions (Net)-$150M$0-$187M-$55M-$70M
Investment Purchases$0-$100M$0$0-$200M
Investment Sales$0$0$102M$0$0
Other Investing$0-$48M-$3M-$6M-$4M
Investing Cash Flow-$221M-$233M-$123M-$86M-$298M
— Financing Activities —
Net Debt Issuance-$21K$0$290M-$70M$0
Stock Repurchased$0$0-$14M$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$3M-$13M-$27M-$17M-$15M
Financing Cash Flow$961K-$13M$249M-$83M-$15M
Net Change in Cash-$113M-$80M$228M$6M-$191M
Cash End of Period$604M$523M$751M$757M$566M
Free Cash Flow$48M$39M$75M$142M$94M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms